Pacer Advisors Inc. Raises Stock Position in Cabot Corporation $CBT

Pacer Advisors Inc. lifted its holdings in Cabot Corporation (NYSE:CBT) by 3,165.7% during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 229,252 shares of the specialty chemicals company’s stock after buying an additional 222,232 shares during the period. Pacer Advisors Inc. owned about 0.44% of Cabot worth $15,195,000 at the end of the most recent reporting period.

Several other hedge funds have also recently made changes to their positions in CBT. Norges Bank purchased a new position in shares of Cabot in the 4th quarter worth approximately $49,662,000. AQR Capital Management LLC raised its holdings in Cabot by 123.0% during the 2nd quarter. AQR Capital Management LLC now owns 867,946 shares of the specialty chemicals company’s stock valued at $65,096,000 after buying an additional 478,702 shares during the period. UBS Group AG lifted its position in Cabot by 186.7% in the third quarter. UBS Group AG now owns 593,510 shares of the specialty chemicals company’s stock worth $45,136,000 after buying an additional 386,514 shares during the last quarter. American Century Companies Inc. lifted its position in Cabot by 8.4% in the third quarter. American Century Companies Inc. now owns 1,805,393 shares of the specialty chemicals company’s stock worth $137,300,000 after buying an additional 140,665 shares during the last quarter. Finally, Healthcare of Ontario Pension Plan Trust Fund purchased a new position in Cabot during the fourth quarter worth $8,785,000. 93.18% of the stock is currently owned by hedge funds and other institutional investors.

Cabot Stock Performance

Shares of Cabot stock opened at $91.43 on Friday. The company has a quick ratio of 0.96, a current ratio of 1.45 and a debt-to-equity ratio of 0.51. The stock’s fifty day moving average is $81.52 and its two-hundred day moving average is $74.78. Cabot Corporation has a 52 week low of $58.33 and a 52 week high of $91.80. The company has a market capitalization of $4.72 billion, a PE ratio of 17.28, a price-to-earnings-growth ratio of 12.07 and a beta of 0.82.

Cabot (NYSE:CBT) last released its earnings results on Tuesday, May 5th. The specialty chemicals company reported $1.61 earnings per share for the quarter, topping the consensus estimate of $1.47 by $0.14. The business had revenue of $904.00 million during the quarter, compared to the consensus estimate of $900.30 million. Cabot had a return on equity of 21.33% and a net margin of 7.97%.The business’s revenue for the quarter was down 3.4% compared to the same quarter last year. During the same period last year, the company earned $1.90 earnings per share. Cabot has set its FY 2026 guidance at 6.000-6.50 EPS. As a group, analysts expect that Cabot Corporation will post 6.34 earnings per share for the current year.

Cabot Increases Dividend

The business also recently disclosed a quarterly dividend, which was paid on Friday, June 12th. Investors of record on Friday, May 29th were issued a dividend of $0.4725 per share. This represents a $1.89 dividend on an annualized basis and a yield of 2.1%. The ex-dividend date was Friday, May 29th. This is a positive change from Cabot’s previous quarterly dividend of $0.45. Cabot’s dividend payout ratio (DPR) is 35.73%.

Analysts Set New Price Targets

A number of research analysts have weighed in on CBT shares. JPMorgan Chase & Co. boosted their price objective on shares of Cabot from $68.00 to $70.00 and gave the company an “underweight” rating in a research report on Wednesday, May 13th. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Cabot in a research note on Tuesday, May 26th. Mizuho upped their price target on shares of Cabot from $75.00 to $80.00 and gave the company a “neutral” rating in a report on Wednesday, May 6th. Wall Street Zen raised shares of Cabot from a “hold” rating to a “buy” rating in a research report on Sunday, June 14th. Finally, Truist Financial began coverage on shares of Cabot in a research note on Monday, June 8th. They issued a “buy” rating and a $98.00 price objective for the company. Two research analysts have rated the stock with a Buy rating, four have given a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat, the stock currently has an average rating of “Hold” and a consensus target price of $83.80.

Cabot Profile

Cabot Corporation is a global specialty chemicals and performance materials company headquartered in Boston, Massachusetts. Founded in 1882 by Godfrey Lowell Cabot, the company has grown into a diversified manufacturer with operations across North America, Europe, Asia and Latin America. Cabot serves a wide range of end markets, including automotive, industrial, energy, and consumer products, supplying essential ingredients that enhance performance, durability and functionality.

The company operates two primary segments: Reinforcement Materials and Performance Materials.